Manuel Sanclemente
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas.
Journal: The Journal of clinical investigation
Published: August 10, 2022
Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.
Journal: Molecular cell
Published: April 07, 2022
RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression.
Journal: Cancer cell
Published: January 29, 2021
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity.
Journal: Cell
Published: November 03, 2020
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 11, 2020
Plk1 overexpression induces chromosomal instability and suppresses tumor development.
Journal: Nature communications
Published: August 16, 2017
c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.
Journal: Cancer cell
Published: July 06, 2017
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.
Journal: Oncotarget
Published: December 21, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026